FDA Inspection 989292 — Midwest Center For Reproductive Health
The FDA completed an inspection of Midwest Center For Reproductive Health on Oct 24, 2016 in Maple Grove, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Maple Grove, MN (United States)